This is unpublished


he, him, his
Physician & Research Faculty
Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Center
Associate Professor, Division of Hematology and Oncology, University of Washington
Innovators Network Endowed Chair
Sites of Practice
Fred Hutchinson Cancer Center - South Lake Union

Photo: Fred Hutch

Education, Training, Board Certifications 

  • M.D., Tehran University of Medical Sciences, Iran 
  • M.P.H., University of Washington 
  • Residency, Cleveland Clinic 
  • Fellowship in Hematology-Oncology, UW 
  • Medical Oncology, American Board of Internal Medicine 
  • Hematology, American Board of Internal Medicine 
  • Internal Medicine, American Board of Internal Medicine 

Clinical Expertise  

  • Chronic lymphocytic leukemia 
  • Lymphoma and lymphoid malignancies 
  • Immunotherapy (CAR T-cell therapy) 
  • Hematopoietic stem cell transplantation 



Research and/or clinical interests 

Dr. Mazyar Shadman is a blood cancer specialist who focuses on lymphoid malignancies. He is involved in clinical research using novel therapeutic agents for lymphoma and chronic lymphocytic leukemia (CLL), immunotherapy (specifically CAR T-cell therapy) for lymphoid neoplasms, and blood stem cell transplantation for hematologic malignancies. His goal is to identify the best treatment sequence or combination for patients with high-risk lymphoma and CLL.

Current research topics include:

  • Therapeutic clinical trials in lymphoid malignancies with a focus on CLL/SLL 
  • CAR T-cell therapy for lymphoma/CLL 
  • Clinical outcome research in lymphoid malignancies  
  • Epidemiology of hematologic malignancies